Regulation of the synthesis, function and degradation of HDM2 (Mdm2 in mouse) plays a key role in controlling the abundance and activity of the transcription factor p53, with consequent implications for the proliferation and survival of normal and cancer cells. We have previously identified the regulation of export of HDM2 mRNA from the nucleus as a novel point of control of HDM2 synthesis. This process is dependent on the activity of the growth factor-regulated MAP-kinase kinases (MEKs). Here, we provide evidence that the eIF4E kinase MNK1 is a key downstream effector of MEKs in this regulatory pathway. We show that HDM2 mRNA export in breast cancer cells is promoted by overexpressed eIF4E in a MEK-and MNK1-dependent manner, and inhibition of MNK1 suppresses endogenous HDM2 mRNA export pathways. This MNK1-and eIF4E-dependent HDM2 regulation occurs through sequences in the 3 0 untranslated region of HDM2 mRNA, and consequently HDM2 mRNA transcripts from both the constitutive P1 and inducible P2 promoters are regulated by this pathway. eIF4E is a known oncogene that is overexpressed in human tumours, including the majority of breast cancers. This pathway, therefore, may play an important role in the dysregulation of HDM2 oncoprotein expression that occurs in many human tumours.
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HDM2 is a key regulator of p53 function in the cell (Vogelstein et al., 2000; Brooks and Gu, 2006) . Domains within the N terminus and central acidic region of HDM2 interact directly with p53 to inhibit the interaction of p53 with transcriptional coactivators, and target it for ubiquitination, export from the nucleus and degradation by the proteasome (Brooks and Gu, 2006; Wallace et al., 2006) . Experimental disruption of the p53-HDM2 interaction can be sufficient to induce the activation of p53-dependent cell cycle arrest and apoptotic pathways (Blaydes et al., 1997; Vassilev et al., 2004) . Multiple stress-response pathways induce p53 activity in cells by regulating HDM2 and the HDM2-p53 interaction (Vogelstein et al., 2000; Wahl and Carr, 2001 ). The rate of HDM2 protein synthesis is critical in determining p53 function in both normal stress responses and during tumorigenesis; increased HDM2 expression due to HDM2 gene amplification is associated with some cancers such as osteosarcoma (Oliner et al., 1992) , and a single nucleotide polymorphism in the HDM2 promoter can result in increased HDM2 protein levels and increased susceptibility to tumorigenesis (Bond and Levine, 2007) . While HDM2 gene amplification is uncommon in most cancers, HDM2 protein levels are frequently increased in many common malignancies including breast, prostate, lung, colon and melanoma (Onel and Cordon-Cardo, 2004) . We have therefore studied how the expression of the human HDM2 gene is regulated at the transcriptional and post-transcriptional level in normal and cancer cells (Phelps et al., 2003 (Phelps et al., , 2005 Phillips et al., 2006a, b) . HDM2 has two promoters, which generate transcripts with alternate 5 0 untranslated regions (UTRs) (exon 1 or 2) but a common coding region and 3 0 UTR (exons 3-12). The P1 promoter is constitutively expressed (Phillips et al., 2006a) , whereas the P2 promoter is highly inducible by p53 (Zauberman et al., 1995) . Growth factor signalling through RAS-RAF-MEK-ERK can also regulate HDM2 protein synthesis, with readily identifiable consequences for cancer cell survival (Shaulian et al., 1997; Ries et al., 2000) . This regulation occurs both through transcriptional regulation at the P2 promoter (Ries et al., 2000; Phelps et al., 2005) and, as we have discovered recently, control of the export of HDM2 mRNA from the nucleus to its sites of translation in the cytoplasm (Phelps et al., 2005) . Bulk export of polyadenylated mRNAs through nuclear pores occurs in metazoan cells through an evolutionarily conserved pathway involving the TAP/NXF1/Mex67p and NXT1/Mtr2p transporter complex (Cullen, 2003; Erkmann and Kutay, 2004) . However, recent studies have demonstrated that certain mRNAs can be organized and exported from the nucleus as functionally related groups, or regulons, by RNA binding proteins (Keene, 2003; Culjkovic et al., 2007) . Examples of such RNA-binding proteins in mammalian cells are HuR (Gallouzi and Steitz, 2001 ) and eIF4E (von der Haar et al., 2004; Culjkovic et al., 2006) . This provides the potential for gene-selective control of mRNA export, though at present little is known regarding how such pathways may be regulated in response to extracellular signals. In order to better understand the mechanisms of MAP-kinase kinase (MEK)-dependent HDM2 mRNA nuclear export, we have now delineated some of the molecular pathways downstream of MEKs that are involved in this process.
A recent report identified HDM2 as one of a number of genes that are regulated at the level of mRNA export by eIF4E (Culjkovic et al., 2006) . As the ability of eIF4E to regulate mRNA export is known to be regulated by its state of phosphorylation (Topisirovic et al., 2004) , we set out to investigate whether it might be involved in the MEK-dependent HDM2 mRNA export we had previously identified in breast cancer cells (Phelps et al., 2005) . Initial characterization of a panel of breast cancer cell lines (data not shown) determined that the T47D line had an approximately twofold greater ratio of cytoplasmic to total HDM2 mRNA than most cell lines, including MCF-7, and therefore we chose to use MCF-7 for experiments aimed at promoting eIF4E-dependent mRNA export and T47D for studies of the inhibition of endogenous HDM2 mRNA export pathways. We first established that transient overexpression of eIF4E in MCF-7 resulted in an increase in Cyclin D1 (Figure 1a ), a protein whose mRNA is well characterized as a target for eIF4E-dependent nuclear export (Rousseau et al., 1996; Culjkovic et al., 2005) . The abundance of HDM2 protein also clearly increased with increasing eIF4E. We then performed an analysis of the subcellular distribution of mRNAs in control-and eIF4E-overexpressing MCF-7 cells to establish whether eIF4E can promote the nuclear export of HDM2 mRNA in these cells ( Figure 1b ). When eIF4E was overexpressed, there were no significant changes in the overall abundance of CYCLIN D1 or HDM2 transcripts in total cell extracts; however, eIF4E caused increases in the cytoplasmic pools of these mRNAs; for HDM2-P1 and -P2 transcripts, these increases were to 174.4±22.3 and 180.8± 3.6% of controls respectively. A reduction in the nuclear fraction was also observed, although this was rather more modest. The difference in the relative changes in transcript levels between nuclear and cytoplasmic fractions is most likely because a high proportion of the HDM2 transcripts are present in the nucleus; in control cells, the relative abundance of HDM2-P1 and -P2 transcripts in the cytoplasm compared to the nucleus was only 15.6±5.4 and 7.4±0.4% respectively.
We then examined the role of kinases involved in the phosphorylation of eIF4E in the regulation of nuclear export of HDM2 mRNA. MEK1 and MEK2 kinases phosphorylate and activate ERK1 and ERK2, which in turn phosphorylate MNK1, an eIF4E serine 209 kinase (Waskiewicz et al., 1997; Mamane et al., 2004) . This is a key post-translational modification of eIF4E that can enhance its ability to promote mRNA transport (Topisirovic et al., 2004) . T47D cells, in addition to having a higher cytoplasmic to total HDM2 mRNA ratio than MCF-7, also exhibited a higher level (169.0±22.6%, n ¼ 4) of constitutive phosphorylation of eIF4E on serine 209 (Figure 2a ), and were therefore used to examine the effect of pharmacological inhibition Figure 1 Overexpression of eIF4E increases the nuclear export of HDM2 transcripts. (a) MCF-7 cells in six-well plates were transfected using Lipofectamine 2000 (Invitrogen, Paisley, UK) with 0-2 mg of eIF4E expression vector pMV7-4E. DNA in all transfections was kept constant using empty vector pMV7. At 48 h post-transfection, western blotting was performed using the following antibodies: HDM2 (monoclonal antibody 2A9; Chen et al., 1993) , Cyclin D1 (Calbiochem, La Jolla, CA, USA), eIF4E (BD Biosciences, Oxford, UK), rabbit anti-b-actin antibody (Sigma Aldrich Co, Poole, UK). (b) MCF-7 cells in 100 mm plates were transfected with 18 mg pMV7 or pMV7-4E 48 h before cellular fractionation by hypotonic lysis (Phillips et al., 2006a) . Following RNA extraction using RNABee (Biogenesis Inc., Poole, UK), cDNA was synthesized using Superscript II reverse transcriptase (Invitrogen) and Taqman quantitative (q)PCR analysis was performed using Taqman Universal PCR Mastermix (Applied Biosystems, Warrington, UK). CYCLIN D1 transcripts were detected using a pre-designed Taqman gene expression assay (Applied Biosystems) and HDM2 transcripts were determined as described previously (Phelps et al., 2005) . Data are normalized to GAPDH. Results are expressed as percentage of transcripts in pMV7-transfected fraction. Black bars, total cell; white bars, nuclear fraction; grey bars, cytoplasmic fraction. Data are representative of three independent experiments. Error bars are s.e.m. of triplicate qPCR assays. Asterisks indicate the significance of the change in transcript abundance in the subcellular fraction, compared to the total cell fraction (*Po0.05, **Po0.01, ***Po0.001; unpaired, two-tailed Student's t-test). Compared to pMV7-transfected controls, GAPDH levels in pMV7-4E-transfected cells were 118.8 ± 6.57, 80.8 ± 6.88 and 76.0 ± 7.28% in total, nuclear and cytoplasmic fractions respectively. Cellular fractionation was validated using semiquantitative reverse transcription-PCR for snRNA U6, scRNA Y4 and GAPDH as described previously (Phelps et al., 2005; Phillips et al., 2006a) . Two PCRs for each fraction are shown, with a threefold difference in the amount of input cDNA to confirm PCRs have not plateaued.
Regulation of HDM2 by eIF4E
A Phillips and JP Blaydes of kinase activity on eIF4E phosphorylation and the subcellular localization of HDM2 mRNA. Inhibition of MEKs with U0126 resulted in decreased eIF4E phosphorylation and a reduction in the abundance of HDM2 and Cyclin D1 proteins (Figure 2b ). We have already demonstrated that this reduction in HDM2 involves both an inhibition of HDM2-P2 promoter activity and reduced nuclear export of both HDM2 mRNA transcripts (Phelps et al., 2005 (Figure 2b) . The results were similar to those obtained following inhibition of MEKs, the inhibitor causing reduced eIF4E phosphorylation at serine 209 and a decrease in HDM2 and Cyclin D1 protein abundance. CGP57380 has recently been shown to inhibit MNK2 as well as MNK1; however, MNK2 activity is MEK-independent and, as U0126 was nearly as effective as CGP57380 at inhibiting eIF4E phosphorylation, it can be concluded that the effects of CGP57380 that we observe are likely to be primarily due to its activity towards MNK1 (Buxade et al., 2005) . Figure 2c shows that inhibition of MNK1 also has similar effects on HDM2 mRNA as those we have previously reported for U1026 (Phelps et al., 2005) .
There was an overall reduction in expression of HDM2-P1 and -P2 transcripts in total cellular RNA (decrease to 53.3 ± 5.5 and 33.1 ± 4.5% of controls respectively), presumably due to inhibition of transcription through an as yet undefined pathway, and a greater decrease when cytoplasmic mRNA was analysed (to 27.6 ± 3.1 and 15.5±1.4% of controls respectively) indicating that HDM2 mRNA export was also inhibited. Nuclear HDM2-P1 and -P2 transcripts were reduced to a lesser extent than in the whole cell fraction (to 73.7±3.4 and 54.3±4.4% of controls respectively), indicating retention of the synthesized HDM2 transcripts in the nucleus. eIF4E-dependent mRNA export has been shown to be mediated by a structurally conserved 4E-sensitivity element present in the 3 0 UTR of transcripts (Culjkovic et al., 2005 (Culjkovic et al., , 2006 . As such an element can be identified in the structure of the 3 0 UTR of HDM2 (Culjkovic et al., 2006) , we cloned the HDM2 3 0 UTR (À15 to þ 2763 relative to the end of the HDM2 coding sequence) 3 0 of the luciferase gene in the HDM2-P2 promoter reporter construct hdm2luc01 and examined its effects on luciferase expression in MCF-7 cells. We first assayed expression from hdm2luc01 or hdm2luc01-3 0 UTR, in the absence or presence of an eIF4E expression vector (Figure 3a ). There was a clear increase (to 171.6±15.3% of control) in relative luciferase activity when eIF4E was overexpressed, only when the reporter vector contained the HDM2 3 0 UTR. This is strong evidence that the HDM2 3 0 UTR does contain a functional 4E response element, which, in this assay, directs the eIF4E-dependent nuclear export of the Figure 2 Inhibitors of eIF4E phosphorylation reduce HDM2 protein expression and inhibit the nuclear export of HDM2 transcripts. (a) MCF-7 and T47D cell lysates were analysed by western blotting. Phospho-Ser-209 eIF4E antibody was purchased from Cell Signaling Technology (Beverly, MA, USA). Data are representative of four independent experiments. (b) T47D cells were cultured for 24 h in the presence of 0.1% dimethylsulphoxide (DMSO) vehicle control, 25 mM U0126 (Promega, Southampton, UK) or 20 mM MNK inhibitor (Calbiochem) before being analysed for expression of the indicated proteins. Quantification of blots from four independent experiments by densitometry demonstrates that, relative to controls, U0126 and the MNK inhibitor reduce phosphorylated eIF4E by 70.6±2.6 and 92.8±4.2% respectively, and HDM2 by 69.6±4.0 and 66.6±7.9%. (c) T47D cells were cultured for 24 h in the presence of 0.1% DMSO or 20 mM MNK1 inhibitor before cellular fractionation by hypotonic lysis. Transcript levels were determined by (q)PCR and presented as in Figure 1b . Results are expressed as percentage of transcripts in the DMSO-treated fraction. Black bars, total cell; white bars, nuclear fraction; grey bars, cytoplasmic fraction. Data are representative of three independent experiments. Error bars are s.e.m. of triplicate qPCR assays. Compared to DMSO-treated controls, GAPDH levels in MNK inhibitortreated cells were 68.9 ± 8.09, 82.4 ± 4.60 and 80.0 ± 4.10% in total, nuclear and cytoplasmic fractions respectively. Cellular fractionation was validated by PCR for snRNA U6, scRNA Y4 as in Figure 1b .
A Phillips and JP Blaydes chimeric mRNA, and consequently enhanced luciferase expression when active eIF4E is present. Note that, in addition to promoting mRNA export, eIF4E also enhances the translation of a specific subset of mRNAs; however, the RNA elements involved in eIF4E-regulated initiation of translation are present in the 5 0 UTR (von der Haar et al., 2004; Mamane et al., 2007) and, combined with our previous findings that inhibition of MEKs has no transcript-selective effect on the association of HDM2 mRNA with polyribosomes, it is unlikely that the effects of the 3 0 UTR are through control of translation.
We then examined the effect of inhibitors of eIF4E phosphorylation on the activity of the reporter gene constructs. As shown in Figure 3bi , while U0126 inhibited HDM2-P2 promoter activity, as we have shown previously (Phelps et al., 2005) , in the absence of the HDM2 3 0 UTR eIF4E overexpression did not confer any additional sensitivity to inhibition of MEKs or MNK1. In contrast, the eIF4E-induced increase in the activity of the hdm2luc01-3 0 UTR vector was ablated by both kinase inhibitors (Figure 3bii) . Therefore, eIF4E-dependent export of HDM2 mRNA to the cytoplasm is dependent upon the activity of both MEK and MNK1 kinases, consistent with the known role of phosphorylation of eIF4E in its regulation of mRNA export (Topisirovic et al., 2004) .
Activation of growth factor-dependent signalling cascades results in the upregulation of p53-activating signalling pathways (Harvey et al., 1993) . In the absence of sufficient activity of its negative-regulatory partner, HDM2, growth factor-stimulated cells will therefore cease proliferating due to the activation of p53-dependent cell cycle arrest or proapoptotic pathways (Blaydes and Wynford-Thomas, 1998) . The coordinated increase in expression of HDM2 in response to the same stimuli is therefore critical in maintaining the dynamic equilibrium of the p53-HDM2 auto-regulatory feedback loop. We have previously identified a MEK-dependent mRNA export pathway as an important component of this regulation in cancer cell lines (Phelps et al., 2005) , and now identify MNK1 and eIF4E as downstream effectors of MEKs that promote HDM2 mRNA export. Our finding that the 3 0 UTR of HDM2 is sufficient to render it sensitive to this export pathway is consistent with the prior identification of eIF4E sensitivity elements that interact with eIF4E in the 3 0 UTRs of other mRNAs, notably CYCLIN D1 (Culjkovic et al., 2005 (Culjkovic et al., , 2006 , and also our finding that both HDM2-P1 and -P2 mRNA transcripts, which differ in their 5 0 UTRs, but contain a common coding sequence and 3 0 UTR, can be exported through a MEK-dependent pathway. Relatively minor perturbations in the normal regulation of HDM2 protein synthesis are sufficient to promote tumour development (Bond et al., 2004) . eIF4E is overexpressed in tumours including a majority of breast carcinomas, and is a known oncogene (Mamane et al., 2004) . Its oncogenic properties are believed to be attributable, at least in part, to its role in mRNAselective nuclear export pathways (Topisirovic et al., 2003 (Topisirovic et al., , 2004 . It seems highly probable that the ability of eIF4E to promote the production of the p53 antagonist HDM2 will be an important contributor to the abnormal proliferation of these tumour cells.
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